TY - JOUR
T1 - Multifocal histologically malignant epstein-barr virus-associated smooth muscle tumor in a pediatric transplant patient with an indolent course
AU - Kazmi, Syed A.Jaffar
AU - Aizenberg, Michele R.
AU - Harper, James L.
AU - McComb, Rodney D.
PY - 2014/4
Y1 - 2014/4
N2 - Epstein-Barr virus-associated smooth muscle tumors (EBV-SMTs) are rare lesions that occur in immunocompromised patients. Dural involvement appears to be less common in organ transplant recipients than in HIV patients. Due to the paucity of reported cases following organ transplantation, the natural history of these lesions is unclear. We describe an 8-year-old female who presented with adrenal, small bowel, and intracranial tumors 6 years following renal transplantation. Histopathological analysis revealed a highly cellular, mitotically active, smooth muscle neoplasm without necrosis. The tumor stained diffusely for smooth muscle actin and myosin. In situ hybridization for EBV-encoded RNA was diffusely positive. Following gross total resection, antiviral therapy, and a reduction in immunosuppression, the patient is tumor-free at 3 years follow-up. In patients with compromised immune systems, it is important to recognize this unique form of SMT because, even when there are multiple lesions, the prognosis may be excellent.
AB - Epstein-Barr virus-associated smooth muscle tumors (EBV-SMTs) are rare lesions that occur in immunocompromised patients. Dural involvement appears to be less common in organ transplant recipients than in HIV patients. Due to the paucity of reported cases following organ transplantation, the natural history of these lesions is unclear. We describe an 8-year-old female who presented with adrenal, small bowel, and intracranial tumors 6 years following renal transplantation. Histopathological analysis revealed a highly cellular, mitotically active, smooth muscle neoplasm without necrosis. The tumor stained diffusely for smooth muscle actin and myosin. In situ hybridization for EBV-encoded RNA was diffusely positive. Following gross total resection, antiviral therapy, and a reduction in immunosuppression, the patient is tumor-free at 3 years follow-up. In patients with compromised immune systems, it is important to recognize this unique form of SMT because, even when there are multiple lesions, the prognosis may be excellent.
KW - EBV
KW - dural tumor
KW - pediatric tumor
KW - smooth muscle tumor
KW - transplant
UR - http://www.scopus.com/inward/record.url?scp=84898970326&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84898970326&partnerID=8YFLogxK
U2 - 10.1177/1066896913494793
DO - 10.1177/1066896913494793
M3 - Article
C2 - 23842005
AN - SCOPUS:84898970326
SN - 1066-8969
VL - 22
SP - 186
EP - 189
JO - International Journal of Surgical Pathology
JF - International Journal of Surgical Pathology
IS - 2
ER -